From the Guidelines
Orcerin C2 is a combination tablet containing Orciprenaline (also known as Metaproterenol) and Chlorpheniramine, with Orciprenaline acting as a beta-2 adrenergic agonist to relax airway smooth muscles and Chlorpheniramine acting as a first-generation antihistamine to block H1 histamine receptors and reduce allergic symptoms. The composition of Orcerin C2 includes two primary components:
- Orciprenaline, a beta-2 adrenergic agonist that works by stimulating beta-2 receptors in bronchial smooth muscle, leading to increased cyclic AMP production and subsequent bronchodilation, which improves breathing in conditions like asthma and chronic obstructive pulmonary disease 1.
- Chlorpheniramine, a first-generation antihistamine that blocks H1 histamine receptors, reducing allergic symptoms such as sneezing, itching, watery eyes, and runny nose, and also has some anticholinergic effects that can help dry secretions. The actions of each component of Orcerin C2 are:
- Orciprenaline: causes bronchodilation by relaxing the smooth muscles in the airways, which is beneficial for conditions like asthma and chronic obstructive pulmonary disease.
- Chlorpheniramine: reduces allergic symptoms by blocking H1 histamine receptors and has anticholinergic effects that help dry secretions. This combination is typically used for respiratory conditions with both bronchospasm and allergic components, such as allergic asthma or bronchitis with allergic manifestations, providing dual action for both bronchodilation and suppression of allergic responses. However, patients may experience side effects including nervousness, tremor, and dry mouth from orciprenaline, while chlorpheniramine may cause drowsiness, dizziness, and urinary retention. It's essential to consider the potential side effects and interactions when prescribing Orcerin C2, and to monitor patients closely for any adverse reactions. In terms of treatment guidelines, the most recent and highest quality study available does not provide specific recommendations for Orcerin C2, but it does emphasize the importance of considering the patient's medical history, current condition, and potential interactions when selecting a treatment regimen 1.
From the Research
Composition of Tablet Oracerin C2
There is no information available in the provided studies about the composition of Tablet Oracerin C2.
Actions of Each Component of the Drug
Since the composition of Tablet Oracerin C2 is not available, it is not possible to determine the actions of each component of the drug.
Relevant Information
- The provided studies discuss the use of various antibiotics, including amoxicillin/clavulanic acid 2, 3, levofloxacin 4, 5, and cephalosporins 6, in the treatment of respiratory tract infections and other conditions.
- These studies provide information on the efficacy, safety, and tolerability of these antibiotics, but do not mention Tablet Oracerin C2.
- Therefore, there is no relevant information available to answer the question about the composition and actions of Tablet Oracerin C2.